BIOMEX at AACC 2022 in Chicago

BIOMEX will have its own booth at this year’s AACC Annual Scientific Meeting & Clinical Lab Expo, which will be held July 26-28 in Chicago.
Neckar Biotechnology, the Chinese branch of BIOMEX, opens its new office in Shanghai

BIOMEX intensifies its China business with the opening of the Neckar Biotechnology branch and new offices in Shanghai.
Support for Ukraine +++ BIOMEX donates 30,000 euros

With a fundraising campaign among its employees, BIOMEX has collected monies to support Ukraine and is donating 30,000 euros to the German-Ukrainian Society Rhine-Neckar e. V.
BIOMEX donates 100,000 euros to the Hopp Children’s Cancer Center KiTZ Heidelberg

With 100,000 Euro, BIOMEX supports the Heidelberg Hopp Children’s Cancer Center KiTZ in the acquisition of a mass spectrometer for cancer analysis and therapy in children.
BIOMEX at Medica 2021

For the first time since 2019, it is again possible to meet customers and partners in person at this year’s MEDICA. We look forward to welcoming you at the BIOMEX booth.
BIOMEX will be present at AACC 2021

As an established partner of the IvD industry, BIOMEX will be on site again this year at the AACC Annual Scientific Meeting & Clinical Lab Expo, September 28-30 in Atlanta.
New Managing Director at BIOMEX!

Dr. Klaus Esperschidt is the new Chief Operating Officer and Managing Director at BIOMEX and is supporting the company in its growth into new markets.
BIOMEX supports Goethe-Corona Fund

BIOMEX supports the Goethe Corona Fund, a joint project of the University of Frankfurt and the University Hospital Frankfurt for Corona emergency aid in India.
COVID-19: Layman study for rapid antigen self-tests in just one week!

In just one week, BIOMEX planned, organized and conducted a COVID-19 layman study for rapid antigen self-testing.
BIOMEX develops unique SARS-CoV-2 immunity seroconversion panels

To support the IvD and life sciences industries in their efforts against the COVID-19 pandemic, BIOMEX is developing new and unique SARS-CoV-2 immunity seroconversion panels.